Skip to main content
OpenTrials
Completed

NCT Number: NCT04021095

Novel Head Protection Prototype Device for Decompression Craniectomy

A proof-of-concept (POC) proposal to study the feasibility of customized head protection prototype device (HPPD) using 3D printed externally-applied moulded skin prosthesis integrated to the craniectomy bony skull defect.

Completed

Looking for future studies?

Notify Me

Key information

Age range

21 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Tan Tock Seng Hospital Rehabilitation Centre

Singapore, 569766

About this study

A proof-of-concept (POC) proposal to study the feasibility of customized head protection prototype device (HPPD) using 3D printed externally-applied moulded skin prosthesis integrated to the craniectomy bony skull defect. The proposed material is a bio-compatible, light-weight rigid /semi rigid material which can be fitted to the skull defect and interfaced with the subject's bony rim using soft, deformable material (e.g. silicon) and attached using an elastic head band or other acceptable means. The prosthesis is removable for skin and prosthesis cleansing and ventilation.

Study Specific Objectives:

(i) Primary Objectives

These are to:

  • test the feasibility and safety of customised 3D printed HPPD,
  • integrate the prostheses to the skull defect in removable manner and discharge patient with appropriate education,
  • to systematically monitor subjects for symptoms, compliance, complications and subjective feedback during the outpatient phase where progressive wear of HPPD and monitoring of acceptability will be monitored.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

All subjects must meet all of the inclusion criteria to participate in this study.

  • Age 21 to 80 years, both males and females.
  • Presence of surgical unilateral or bilateral craniectomy performed for reasons of ischaemic or haemorrhagic stroke, Subarachnoid haemorrhage (SAH), traumatic brain injury (TBI), benign cerebral tumours, etc.
  • Stroke, SAH or TBI are diagnosed by specialists and confirmed on brain imaging studies (CT, MRI)
  • Duration from event > 30 days and either during inpatient or outpatient phase.
  • Presence of at least 1 post decompressive craniectomy CT brain film performed at NNI/TTSH.
  • Healed craniectomy surgical wound without bulging skin flap or active skin infection.
  • Patients awaiting elective cranioplasty or those who refuse cranioplasty. 8 Ability to understand simple instructions and give own consent. 9 Presence of family members or NOK who can supervise the patient to don the head protection device, care for the material and regularly monitor for compliance and complications 10 Reproductive age females should not be pregnant at the point of consent-taking and during the study

Exclusion criteria

  • Patient in vegetative or minimally responsive state.
  • Presence of uncontrolled medical condition (uncontrolled hypertension, Diabetes Mellitus, sepsis or delirium, active malignancy either cranial or extracranial sites)
  • Presence of end organ failure (end stage renal or liver failure, renal dialysis, life expectancy <6 months)
  • Presence of pregnancy or lactation.
  • Presence of severe agitation /behavioural/active depression or anxiety/ drug or alcohol addiction which would negatively affect compliance,
  • Presence of unhealed head wound, active wound infection, scalp dermatitis, wound breakdown which would be worsened by pressure from the HPPD.
  • Presence of known allergy to the investigational products which is the 3D printed material (e.g. Nylon).
  • Subjects' CT brain imaging films are not available to the study team.
  • Absence of NOK who can assist monitoring unless subjects is able to self-monitor

Treatment and study plan

Head protection prototype device

Device

The proposed experimental HPPD uses biocompatible material using FDMÔNylon which has high fatigue resistance, chemical resistance with impact resistance and toughness which is free of powders. It is HSA unclassified as yet and the FDMONylon is not FDA approved yet.

Primary outcomes

  1. Percentage of acute complications at second hour of HPPD fitting

    Time frame: 12 months

    Complications are defined as immediate complaints of pain or discomfort and /or signs of bony defect scar pressure redness or wound breakdown within the first 2 hours in the research clinic.

Secondary outcomes

  1. Percentage of acute complications at end of first week of HPPD use.

    Time frame: 12 months

    Complications are defined as pain or discomfort or signs of bony defect scar pressure or redness or wound breakdown in the first week post-fitting of HPPD

Sponsors and collaborators

Lead sponsor

Tan Tock Seng Hospital

Other

Collaborators

  • Creatz3D

Registry information

Official study title

An Exploratory Study on the Development of a Novel Head Protection Prototype Device for Post-decompression Craniectomy Patients

Acronym: HPPD

Important dates

Study start
2019
Primary completion
2021
Study completion
2021
First posted
Jul 16, 2019
Registry last updated
Apr 1, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.